Limax Biosciences, Inc.
Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.
Limax Biosciences, Inc.
What We Do
HemoMax
A tough gel adhesive that helps prevent bleeding-related complications during surgical procedures, replaces staples and sutures, and delivers drugs locally to minimize systemic side effects.
Biologics
Key People
Benjamin Freedman, PhD
Co-founder
David Mooney, PhD
Co-founder
Phoebe Kwon
Research Scientist
Christopher Johnson
Support/Consultant
Adam Hacking, PhD
Advisor
Anh Hoang, PhD
Advisor
News & Updates
Grants Awarded
Grants have been awarded by the Bill & Melinda Gates Foundation and by NSF Innovation Corps for Customer Discovery and Validation.
Winner of Innovation Challenges
Limax was the winner in Harvard University President's Innovation Challenge (2022), MassChallenge (2023), MedTech Innovator (Value Competition, 2022), and Advanced Technology International (ATI) and TechConnect's Medical Innovation Challenge (2022).
Accelerator Programs
Limax Biosciences is a member of the JLabs family as a QuickFire Challenge Award Recipient.
1st Place in Harvard President's Innovation Challenge
Limax Biosciences team won first-place prize in the Health & Life Sciences Track of the 2022 Harvard President's Innovation Challenge.